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Dear Editor,
We read with interest an article by Sheybani et al. (1) demonstrating the assessment of fluid
dynamics and flow control between the XEN 45 micro-fistula implant, the EX-PRESS® implant (Alcon
Laboratories, Inc., Fort Worth, TX, USA) and silicone tubing from a Baerveldt implant (Abbott
Medical Optics, Abbott Park, IL, USA). The authors demonstrated that the Hagen-Poiseuille equation
can be used to calculate the required dimensions of a tube that would prevent hypotony at average
aqueous humour production and that the EX-PRESS® device, when placed without a sclera flap,
results in hypotony.
It is described in the article that the EX-PRESS® device has an opening of 200m in inner diameter
that tapers to a 50m inner lumen. Our group have previously reported our evaluation of the EX-
PRESS® device. (2) There are two device models available, the P50 and the P200, with advertised
50m and 200m luminal internal diameters (ID) respectively. Esterman et al. (3) previously
reported that the resistance to the flow with the EX-PRESS® device would decrease by 256 times if
the luminal diameter were increased by 4 times, as expected from the Hagen-Poiseuille equation.
However, they only observed a resistance value obtained with the P200 device in the order of 6 to 7
times lower than the P50 device, a finding we previously corroborated in our own study. (2)
The reduction in resistance with increased lumen ID cannot be explained with the Hagen-Poiseuille
equation on the basis of their lumen ID criteria alone. On scanning electron microscopy, we
observed that the internal diameter of the lumen of both the P50 and P200 were in the region of
200m at both the subconjunctival space and anterior chamber end. We confirmed with Alcon Inc.
that the P50 differs from the P200 only in having a 150m diameter bar lying across its lumen in the
middle of the device. The P50 and P200 devices also have a side orifice at the anterior chamber end
of their bodies, which means they do not have a constant circular cross section. This, together with
the presence of the bar lying across the lumen of the P50 device, means that Poiseuille’s Law is not
applicable.
Sheybani et al also state that the EX-PRESS® does not provide significant outflow resistance. We too
observed that there were minimal differences in pressures between the EX-PRESS® device and a
typical trabeculectomy. However, we observed that device implantation resulted in less variability in
pressure readings and this may be due to more consistent lumen sizes with small tolerances, as
compared to making a sclerostomy with a punching device or knife. We also observed that more
manipulation was required subjectively with a smaller 27 G versus 25 G needle stab on device
insertion. This may result in a poorer fit around the body of the device, resulting in leakage.
We agree with Sheybani et al. that use of the EX-PRESS® device without a scleral flap carries
significant risk of hypotony and has similar equilibrium pressures as the trabeculectomy procedure.
We would highlight that the effective luminal diameter of the P50 is much larger than 50m and
that intra-operative surgical technique may reduce tissue manipulation and therefore reduce post-
operative pressure fluctuations.
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